NCT00551213 2018-08-24A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)Merck Sharp & Dohme LLCPhase 2 Completed67 enrolled 12 charts